141 related articles for article (PubMed ID: 18748601)
1. Pathology-Epitomes of Progress: Prostatic Acid Phosphatase (Male PAP).
Finck FM
West J Med; 1980 Apr; 132(4):347-8. PubMed ID: 18748601
[No Abstract] [Full Text] [Related]
2. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
Gaca A; Panitz N
Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
[TBL] [Abstract][Full Text] [Related]
3. Urology-epitomes of progress: detection of specific prostatic Acid phosphatase.
Nachtsheim DA
West J Med; 1981 Apr; 134(4):346-7. PubMed ID: 18748852
[No Abstract] [Full Text] [Related]
4. The histochemical demonstration of human prostatic acid phosphatase with phosphorylcholine.
Serrano JA; Wasserkrug HL; Serrano AA; Paul BD; Seligman AM
Invest Urol; 1977 Sep; 15(2):123-36. PubMed ID: 71283
[TBL] [Abstract][Full Text] [Related]
5. Pathology-epitomes of progress: pap smears-lest we forget.
Perry RA
West J Med; 1980 Apr; 132(4):345. PubMed ID: 18748599
[No Abstract] [Full Text] [Related]
6. A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.
van Dieijen-Visser MP; Delaere KP; Gijzen AH; Brombacher PJ
Clin Chim Acta; 1988 May; 174(2):131-40. PubMed ID: 2454767
[TBL] [Abstract][Full Text] [Related]
7. Design of spindle poisons activated specifically by prostatic acid phosphatase (PAP) and new methods for PAP cytochemistry.
Seligman AM; Sternberger NJ; Paul BD; Friedman AE; Shannon WA; Wasserkrug HL; Plapinger RE; Lynm D
Cancer Chemother Rep; 1975; 59(1):233-42. PubMed ID: 805658
[TBL] [Abstract][Full Text] [Related]
8. Endogenous protein substrates for prostatic acid phosphatase in human prostate.
Lee H; Chu TM; Lee CL
Prostate; 1991; 19(3):251-63. PubMed ID: 1719511
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
Sakai H; Shiraishi K; Minami Y; Yushita Y; Kanetake H; Saito Y
Prostate; 1991; 19(3):265-72. PubMed ID: 1946042
[TBL] [Abstract][Full Text] [Related]
10. [Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay].
Fuse H; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1986 Dec; 32(12):1813-9. PubMed ID: 2435130
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Buamah PK; Johnson P; Skillen AW
Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396
[TBL] [Abstract][Full Text] [Related]
12. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
el-Shirbiny AM; Shridhar P; al Adnani MS; Suresh LK
Urology; 1988 Nov; 32(5):469-73. PubMed ID: 2460989
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a new solid-phase direct immunoenzyme assay for prostatic acid phosphatase.
Gericke K; Kohse KP; Pfleiderer G; Flüchter SH; Bichler KH
Clin Chem; 1982 Apr; 28(4 Pt 1):596-602. PubMed ID: 7042116
[TBL] [Abstract][Full Text] [Related]
14. Prostatic acid phosphatase is the main acid phosphatase with 5'-ectonucleotidase activity in the male mouse saliva and regulates salivation.
Araujo CL; Quintero IB; Kipar A; Herrala AM; Pulkka AE; Saarinen L; Hautaniemi S; Vihko P
Am J Physiol Cell Physiol; 2014 Jun; 306(11):C1017-27. PubMed ID: 24717577
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
Tsukamoto T; Kumamoto Y; Yamazaki K; Umehara T; Miyao N; Ohmura K; Iwazawa M
Hinyokika Kiyo; 1988 Jun; 34(6):987-95. PubMed ID: 2464917
[TBL] [Abstract][Full Text] [Related]
16. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological approaches to human prostatic epithelial cells.
Choe BK; Pontes JE; Lillehoj HS; Rose NR
Prostate; 1980; 1(4):383-98. PubMed ID: 7024956
[TBL] [Abstract][Full Text] [Related]
19. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
Salo JO; Rannikko S; Haapiainen R
Br J Urol; 1990 Aug; 66(2):188-92. PubMed ID: 1697205
[TBL] [Abstract][Full Text] [Related]
20. Macro-prostatic acid phosphatase in a patient's serum.
Schifferli JA; Roth P; Steiger G; Paccaud JP; Schmidt M
Clin Chem; 1988 Oct; 34(10):2172-4. PubMed ID: 3168257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
